XML 126 R107.htm IDEA: XBRL DOCUMENT v3.25.1
Supplemental Financial Information - Cash Flows (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Cash flows from operating activities      
Net income $ 158.6 $ 98.8  
Adjustments to reconcile net income to net cash flows from operating activities:      
Depreciation and amortization 46.9 45.3  
Equity-based compensation 103.5 108.3  
Non-cash performance allocations and incentive fees 15.0 190.9  
Non-cash principal investment income (loss) 72.7 (70.0)  
Other non-cash amounts 12.6 (2.9)  
Purchases of investments (78.3) (145.1)  
Proceeds from the sale of investments 144.8 102.1  
Payments of contingent consideration (1.0) (1.5)  
Changes in deferred taxes, net (29.4) (47.1)  
Change in due from affiliates and other receivables 10.7 6.7  
Change in deposits and other (10.8) (19.7)  
Change in accounts payable, accrued expenses and other liabilities (25.4) 41.5  
Change in accrued compensation and benefits (327.7) (365.6)  
Change in due to affiliates 6.5 (2.2)  
Change in lease right-of-use assets and lease liabilities (2.8) (2.2)  
Change in deferred revenue 280.2 251.6  
Net cash (used in) provided by operating activities (352.1) 71.1  
Cash flows from investing activities      
Purchases of fixed assets, net (16.7) (14.2)  
Net cash used in investing activities (16.7) (14.2)  
Cash flows from financing activities      
Payments on CLO borrowings (14.6) (13.9)  
Proceeds from CLO borrowings, net of financing costs 15.1 0.0  
Dividends to common stockholders (126.4) (126.7)  
Payment of deferred consideration for Carlyle Holdings units 0.0 (68.8)  
Contributions from non-controlling interest holders 163.0 64.7  
Distributions to non-controlling interest holders (164.2) (19.0)  
Common shares repurchased and net share settlement of equity-based awards (176.5) (150.0)  
Change in due to/from affiliates financing activities 40.8 51.7  
Net cash provided by (used in) financing activities 296.6 (216.7)  
Effect of foreign exchange rate changes 5.0 (4.4)  
Decrease in cash, cash equivalents and restricted cash (67.2) (164.2)  
Cash, cash equivalents and restricted cash, beginning of period 1,266.5 1,442.1  
Cash, cash equivalents and restricted cash, end of period 1,199.3 1,277.9  
Reconciliation of cash, cash equivalents and restricted cash, end of period:      
Cash and cash equivalents 1,190.3 1,276.5 $ 1,266.0
Restricted cash 9.0 1.4 0.5
Total cash, cash equivalents and restricted cash, end of period 1,199.3 1,277.9 1,266.5
Cash and cash equivalents held at Consolidated Funds 570.9 426.0 830.4
Consolidated Operating Entities      
Cash flows from operating activities      
Net income 150.6 86.1  
Adjustments to reconcile net income to net cash flows from operating activities:      
Depreciation and amortization 46.9 45.3  
Equity-based compensation 103.5 108.3  
Non-cash performance allocations and incentive fees 14.5 189.6  
Non-cash principal investment income (loss) 69.6 (68.1)  
Other non-cash amounts 12.6 (2.9)  
Purchases of investments (290.9) (215.1)  
Proceeds from the sale of investments 155.1 108.3  
Payments of contingent consideration (1.0) (1.5)  
Changes in deferred taxes, net (29.4) (47.1)  
Change in due from affiliates and other receivables 12.7 7.9  
Change in deposits and other (10.8) (19.7)  
Change in accounts payable, accrued expenses and other liabilities (25.4) 41.5  
Change in accrued compensation and benefits (327.7) (365.6)  
Change in due to affiliates 6.5 (2.2)  
Change in lease right-of-use assets and lease liabilities (2.8) (2.2)  
Change in deferred revenue 280.2 251.6  
Net cash (used in) provided by operating activities 164.2 114.2  
Cash flows from investing activities      
Purchases of fixed assets, net (16.7) (14.2)  
Net cash used in investing activities (16.7) (14.2)  
Cash flows from financing activities      
Payments on CLO borrowings (14.6) (13.9)  
Proceeds from CLO borrowings, net of financing costs 15.1 0.0  
Dividends to common stockholders (126.4) (126.7)  
Payment of deferred consideration for Carlyle Holdings units 0.0 (68.8)  
Contributions from non-controlling interest holders 57.7 62.5  
Distributions to non-controlling interest holders (16.9) (19.0)  
Common shares repurchased and net share settlement of equity-based awards (176.5) (150.0)  
Change in due to/from affiliates financing activities 42.3 56.7  
Net cash provided by (used in) financing activities (219.3) (259.2)  
Effect of foreign exchange rate changes 4.6 (5.0)  
Decrease in cash, cash equivalents and restricted cash (67.2) (164.2)  
Cash, cash equivalents and restricted cash, beginning of period 1,266.5 1,442.1  
Cash, cash equivalents and restricted cash, end of period 1,199.3 1,277.9  
Reconciliation of cash, cash equivalents and restricted cash, end of period:      
Cash and cash equivalents 1,190.3 1,276.5  
Restricted cash 9.0 1.4  
Total cash, cash equivalents and restricted cash, end of period 1,199.3 1,277.9 $ 1,266.5
Cash and cash equivalents held at Consolidated Funds $ 570.9 $ 426.0